Healthy Extracts (HYEX) Cash from Operations Growth (3y) (2018 - 2025)
Healthy Extracts (HYEX) Cash from Operations Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 8.25% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 52.97% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 5.90% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 43.42% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -10.08% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -8.76% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 65.60% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Healthy Extracts | 19.90 Mn | 19.71 Mn | 1.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65.16% |
| Sep 30, 2025 | -48.00% |
| Jun 30, 2025 | 32.99% |
| Mar 31, 2025 | 36.69% |
| Dec 31, 2024 | 0.81% |
| Sep 30, 2024 | 29.89% |
| Jun 30, 2024 | 91.57% |
| Mar 31, 2024 | 26.61% |
| Dec 31, 2023 | -61.65% |
| Sep 30, 2023 | 59.79% |
| Jun 30, 2023 | 66.89% |
| Mar 31, 2023 | -25.04% |
| Dec 31, 2022 | -28.44% |
| Sep 30, 2022 | 52.17% |
| Mar 31, 2022 | 63.21% |
| Dec 31, 2021 | 122.83% |
| Sep 30, 2021 | -131.52% |
| Jun 30, 2021 | 33.45% |
| Mar 31, 2021 | -50.01% |
| Dec 31, 2020 | 80.47% |